Target Name: GABRR2
NCBI ID: G2570
Review Report on GABRR2 Target / Biomarker Content of Review Report on GABRR2 Target / Biomarker
GABRR2
Other Name(s): GABA(A) receptor rho-2 subunit | Gamma-aminobutyric acid type A receptor subunit rho2 | Gamma-aminobutyric acid receptor subunit rho-2 | gamma-aminobutyric acid (GABA) A receptor, rho 2 | gamma-aminobutyric acid type A receptor subunit rho2 | Gamma-aminobutyric acid (GABA) receptor, rho 2 | GABA-C receptor, rho-2 subunit | gamma-aminobutyric acid type A receptor rho2 subunit | GBRR2_HUMAN | GABA(A) receptor subunit rho-2 | GABA(C) receptor

GABRR2: A Potential Drug Target and Biomarker for GABA(A) Receptor Function

GABA(A) receptors, also known as GABA receptors, are a family of ion channels that play a crucial role in neurotransmission. These receptors are involved in the regulation of various physiological processes, including sleep, pain, and anxiety. The GABA(A) ) receptor rho-2 subunit is a protein that is associated with the function of GABA(A) receptors. It is a subunit of the GABA(A) receptor, which consists of two subunits: GABA(A) and GABAB. The GABAB subunit is responsible for the ligand binding and activation of the GABA(A) receptor.

GABRR2, also known as GABA(A) receptor rho-2 subunit, is a protein that is expressed in various tissues and cells in the body. It is a key component of the GABA(A) receptor, and its function is essential for the regulation of various physiological processes. GABRR2 plays a crucial role in the regulation of pain perception, anxiety, and sleep.

GABRR2 is involved in the regulation of pain perception. GABA(A) receptors are involved in the regulation of pain perception, and GABRR2 is involved in the modulation of pain perception. Research shows that GABRR2 is involved in the regulation of pain perception by modulating the release of endogenous opioids, such as endorphins, from the endoplasmic system.

GABRR2 is involved in the regulation of anxiety and sleep. GABA(A) receptors are involved in the regulation of anxiety and sleep, and GABRR2 is involved in both of these processes. Studies have shown that GABRR2 is involved in the regulation of anxiety by modulating the function of GABA(A) receptors. GABRR2 has been shown to interact with several neurotransmitters, including GABA, which is a neurotransmitter that is involved in the regulation of anxiety and sleep.

GABRR2 may also be a potential biomarker for GABA(A) receptor function. GABA(A) receptors are involved in the regulation of various physiological processes, including sleep, pain, and anxiety. As such, GABRR2 may be a potential biomarker for the function. of GABA(A) receptors. Studies have shown that GABRR2 is involved in the regulation of sleep, pain, and anxiety, and its levels have been shown to be affected by various factors, including stress, exercise, and alcohol.

In conclusion, GABRR2 is a protein that is involved in the regulation of various physiological processes, including pain perception, anxiety, and sleep. Its function is essential for the regulation of these processes, and it may be a potential drug target and biomarker for GABA (A) receptor function. Further research is needed to fully understand the role of GABRR2 in the regulation of pain perception, anxiety, and sleep, as well as its potential as a drug target and biomarker.

Protein Name: Gamma-aminobutyric Acid Type A Receptor Subunit Rho2

Functions: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel. Rho-2 GABA receptor could play a role in retinal neurotransmission

The "GABRR2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GABRR2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GABRR3 | GACAT1 | GACAT2 | GACAT3 | GAD1 | GAD2 | GADD45A | GADD45B | GADD45G | GADD45GIP1 | GADL1 | GAGE1 | GAGE10 | GAGE12B | GAGE12C | GAGE12D | GAGE12F | GAGE12G | GAGE12H | GAGE12J | GAGE2A | GAGE2B | GAGE2C | GAGE2D | GAGE4 | GAGE5 | GAGE6 | GAGE7 | GAGE8 | GAK | GAL | GAL3ST1 | GAL3ST2 | GAL3ST3 | GAL3ST4 | Galanin receptor | GALC | GALE | GALK1 | GALK2 | GALM | GALNS | GALNT1 | GALNT10 | GALNT11 | GALNT12 | GALNT13 | GALNT13-AS1 | GALNT14 | GALNT15 | GALNT16 | GALNT17 | GALNT18 | GALNT2 | GALNT3 | GALNT4 | GALNT5 | GALNT6 | GALNT7 | GALNT7-DT | GALNT8 | GALNT9 | GALNT9-AS1 | GALNTL5 | GALNTL6 | GALP | GALR1 | GALR2 | GALR3 | GALT | Gamma Crystallin | Gamma-Aminobutyric acid type B receptor | Gamma-aminobutyric-acid A receptor, Rho | gamma-delta T Cell Receptor (TCR) Complex | Gamma-glutamyl transferase | gamma-Secretase | Gamma-tubulin complex | GAMT | GAN | GANAB | GANC | Gap junction Connexin ( | Gap Junction Protein | GAP43 | GAPDH | GAPDHP1 | GAPDHP14 | GAPDHP21 | GAPDHP38 | GAPDHP42 | GAPDHP56 | GAPDHP62 | GAPDHP65 | GAPDHP72 | GAPDHS | GAPLINC | GAPT | GAPVD1 | GAR1 | GAREM1